0001363585-13-000005.txt : 20130401 0001363585-13-000005.hdr.sgml : 20130401 20130401162438 ACCESSION NUMBER: 0001363585-13-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130401 FILED AS OF DATE: 20130401 DATE AS OF CHANGE: 20130401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Von Hofe Eric CENTRAL INDEX KEY: 0001533548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 13731471 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO STATE: A6 ZIP: M5J2G2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-04-01 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001533548 Von Hofe Eric 555 RICHMOND STREET WEST TORONTO A6 M5V 3B1 ONTARIO, CANADA 1 0 0 0 Common Stock Purchase Option (right to buy) 0.001 2013-04-01 4 A 0 2177267 0 A 2013-04-01 2018-04-01 COMMON STOCK 2177267 2177267 D On March 5, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 2,177,267 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective April 1, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan. ERIC VON HOFE 2013-04-01